Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov:100:107694.
doi: 10.1016/j.ijscr.2022.107694. Epub 2022 Sep 21.

Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature

Fatimah Al Jaber  1 , Eman Almaher  2 , Rawan Al-Ibrahim  3 , Mohammed AlQahtani  4
Affiliations
Case Reports

Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature

Fatimah Al Jaber et al. Int J Surg Case Rep. 2022 Nov.

Abstract

Background: Gallbladder cancer is a rare type of malignancy with overall poor prognosis. It represents the most common type of biliary tract cancer. Surgical resection can provide cure for those presenting in early stages. However, patients presenting with locally advanced or metastatic disease are considered unresectable and the first line of management in such cases is chemotherapy.

Case presentation: 60 years old Saudi female with no previous medical background who was diagnosed at local hospital to have unresectable metastatic gallbladder cancer to the liver. She received 6 cycles of neoadjuvant chemotherapy as the standard protocol (Gemcitabin + Cisplatin). She showed a good response and after a multidisciplinary tumor board decision was then taken for a successful curative surgical resection (R0). Post operatively, she had another 4 cycles adjuvant chemotherapy of the same regimen. She is still on active surveillance, alive in a good condition with no local recurrence or distant metastasis after 42 months post operatively.

Discussion: Patients with gallbladder cancer are often diagnosed at late stages and those with locally advanced or metastatic gallbladder cancer are not candidates for surgical resection, even though it is a principal part of management to achieve cure. A conversion surgical resection is yet possible in selected patients initially labeled as having unresectable gallbladder cancer following neoadjuvant chemotherapy.

Conclusion: A conversion surgical resection can achieve cure in appropriately selected candidates initially labeled as unresectable gallbladder cancer following good response to neoadjuvant chemotherapy. Careful patient selection and multidisciplinary team management is recommended. Further studies are needed to standardized the management approach regarding criteria for eligible candidates, timing before considering conversion, and extent of resection.

Keywords: Conversion surgery; Curative surgical resection; Gemcitabin plus cisplatin; Unresectable gallbladder cancer.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None.

Figures

Fig. 1
Fig. 1
Initial CT.
Fig. 2
Fig. 2
Post chemotherapy.
See this image and copyright information in PMC

References

    1. NCCN © 2022 National Comprehensive Cancer Network® Version 1.2022, 03/29/22.
    1. Morimoto H., Ajiki T., Takase S., Fujita T., Matsumoto T., Mita Y., et al. Resection of gallbladder cancer with hepatic metastasis after chemotherapy with gemcitabine. J. Hepato-Biliary-Pancreat. Surg. 2008;15:655–658. - PubMed
    1. Takita M., Iwasaki E., Hatogai K., Kishino R., Seki E., Izumiya M., et al. Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy. Nihon Shokakibyo Gakkai Zasshi. 2011;108:1263–1270. - PubMed
    1. Kato A., Shimizu H., Ohtsuka M., Yoshidome H., Yoshitomi H., Furukawa K., et al. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single center study. Ann. Surg. Oncol. 2013;20:318–324. - PubMed
    1. Einama T., Uchida K., Taniguchi M., Ota Y., Watanabe K., Imai K., et al. Successful curative resection of gallbladder cancer following S-1 chemotherapy: a case report and review of the literature. Oncol. Lett. 2014;8:2443–2447. - PMC - PubMed

Publication types